Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Hexarelin for Women: Type Comparison

Hexarelin Ghrelin receptor (GHS-R1a) agonist High-amplitude pulse (10–15× baseline), peaks 20–30 min, returns to baseline in 3–4 hours Acute glucose elevation, chronic use may improve insulin sensitivity via IGF-1 Moderate. Tachyphylaxis observed after 8–12 we

This comparison does not assign a generated winner or score.

  • Hexarelin
  • Ghrelin receptor (GHS-R1a) agonist
  • High-amplitude pulse (10–15× baseline), peaks 20–30 min, returns to baseline in 3–4 hours
  • Acute glucose elevation, chronic use may improve insulin sensitivity via IGF-1
  • Moderate. Tachyphylaxis observed after 8–12 weeks of daily use
  • Best for pulsed protocols; powerful GH response but requires cycling or intermittent dosing to preserve receptor sensitivity
  • GHRP-2
  • Ghrelin receptor agonist (weaker affinity than hexarelin)
  • Moderate pulse (6–8× baseline), similar kinetics
  • Minimal acute hyperglycemia; better for insulin-sensitive populations
  • Low. Less receptor downregulation than hexarelin
  • Gentler alternative to hexarelin with lower desensitization risk; suitable for longer continuous protocols
  • Ipamorelin
  • Selective ghrelin receptor agonist (no cortisol/prolactin elevation)
  • Moderate pulse (5–7× baseline), highly selective for GH
  • Negligible insulin impact
  • Very low. Most forgiving long-term
  • Ideal for women prioritizing minimal side effects; lacks the appetite stimulation and cortisol spikes seen with hexarelin
  • Sermorelin
  • GHRH (growth hormone-releasing hormone) analog
  • Moderate pulse (4–6× baseline), dependent on pituitary GHRH receptor availability
  • Neutral to slightly favorable
  • None. Works through GHRH pathway, not ghrelin
  • Best for younger women with intact pituitary function; less effective in aging populations with blunted GHRH receptors
  • CJC-1295 (no DAC)
  • GHRH analog, short half-life
  • Moderate sustained pulse (3–5 hours elevated), mimics natural GHRH
  • Neutral
  • None
  • Often stacked with ghrelin agonists (e.g., hexarelin or ipamorelin) for dual-pathway GH stimulation; synergistic when combined